In 2024, Medicaid providers in Feasterville recorded $1,610,895 in charges for Pathology and Laboratory Procedures, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database. This total was 4.8% higher compared to 2023, when $1,536,713 in claims was submitted for the same category.
Medicaid, a state-run program financed through both federal and state sources, insures low-income people, families, seniors, children and those with disabilities, making it a major component of the U.S. health system.
Because taxpayer funds support Medicaid, shifts in local billing reflect where public health care spending is targeted within a community.
The “Pathology and Laboratory Procedures” group consists of Medicaid-billed services identified by specific types of care, based on standardized HCPCS and CPT code groupings. This analysis assigned each billing code to a single service group using established code prefixes and number blocks, ensuring that similar services could be analyzed collectively while preventing duplicate counts and keeping rankings consistent over time.
Pathology and Laboratory Procedures was the leading category for total Medicaid payouts in Feasterville for 2024, despite overall increases across several service groups.
Statewide in Pennsylvania, Pathology and Laboratory Procedures ranked ninth in Medicaid payment totals in 2024.
Looking at the five years preceding 2024, Feasterville’s Medicaid spending in this category rose by $745,631, or 31.6%. Some periods saw more rapid growth, including significant annual increases in 2020 and 2021.
While Pathology and Laboratory Procedures claims occurred throughout Feasterville, spending was notably higher in a few ZIP codes. In 2024, ZIP code 19053 saw Medicaid payments reach $1,610,894 for this category. This ZIP code alone represented 100% of all Medicaid spending for Pathology and Laboratory Procedures in Feasterville that year.
Within the category, Medicaid spending was mostly focused on a small group of billing codes.
When compared to all Medicaid claim categories in Feasterville, the 4.8% increase for Pathology and Laboratory Procedures between 2024 and 2023 stands against a broader 20.9% change across service groups during the same period.
According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid expenditures reached about $871.7 billion in fiscal year 2023, or roughly 18% of all national health spending. This was a significant rise from the $613.5 billion reported in 2019, prior to the COVID-19 pandemic.
This change marks approximately 40% growth over several years, primarily resulting from expanded participation and greater use of services during and following the pandemic.
Recent federal budget measures enacted during the Trump administration included major proposals affecting Medicaid funding and the program’s structure. The “One Big Beautiful Bill Act,” signed in 2025, is expected to reduce federal Medicaid funding by more than $1 trillion over a decade and introduces new policies, such as work mandates and increased cost-sharing, that could decrease coverage and funding for certain groups. These changes are projected to place more responsibility on states and slow the growth of federal Medicaid contributions, even as many Americans continue to rely on the program.
| Year | Total Medicaid Payments | % Change From Previous Year |
|---|---|---|
| 2020 | $2,356,525 | 90.4% |
| 2021 | $2,766,642 | 17.4% |
| 2022 | $1,847,745 | -33.2% |
| 2023 | $1,536,712 | -16.8% |
| 2024 | $1,610,894 | 4.8% |
| Rank | Category | Medicaid Payments | Share of City Total |
|---|---|---|---|
| 1 | Pathology and Laboratory Procedures | $1,610,894 | 63.8% |
| 2 | Ambulance and Other Transport Services and Supplies | $580,098 | 23% |
| 3 | Procedures / Professional Services | $194,912 | 7.7% |
| 4 | Medicine Services and Procedures | $87,667 | 3.5% |
| 5 | Evaluation and Management | $33,583 | 1.3% |
| 6 | Coronavirus Diagnostic Panel | $13,745 | 0.5% |
| 7 | Surgery | $3,505 | 0.1% |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87798 | Detect agent nos dna amp | $316,509 | 12 |
| 87150 | Dna/rna amplified probe | $170,049 | 12 |
| 87633 | Resp virus 12-25 targets | $98,591 | 9 |
| 80307 | Drug test prsmv chem anlyzr | $95,354 | 12 |
| 87481 | Candida dna amp probe | $72,195 | 12 |
| 82306 | Vitamin d 25 hydroxy | $55,299 | 12 |
| 87591 | N.gonorrhoeae dna amp prob | $36,065 | 12 |
| 87491 | Chlmyd trach dna amp probe | $35,943 | 12 |
| 80061 | Lipid panel | $35,902 | 12 |
| 80074 | Acute hepatitis panel | $32,596 | 12 |
| 87661 | Trichomonas vaginalis amplif | $29,662 | 12 |
| 87500 | Vanomycin dna amp probe | $25,711 | 12 |
| 87653 | Strep b dna amp probe | $25,626 | 12 |
| 87640 | Staph a dna amp probe | $25,522 | 12 |
| 84443 | Assay thyroid stim hormone | $25,074 | 12 |
| 82607 | Vitamin b-12 | $24,949 | 12 |
| 80050 | General health panel | $24,685 | 12 |
| 83036 | Hemoglobin glycosylated a1c | $24,423 | 12 |
| 87799 | Detect agent nos dna quant | $21,896 | 12 |
| 80053 | Comprehen metabolic panel | $19,783 | 12 |
Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.
Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.








